Study to Determine the Bioequivalence of Two Products Containing Rosuvastatin (20 mg/Tablet)

NCT02767310 · clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
49
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Verisfield UK Ltd. Greek Branch